首页|清咳平喘颗粒对COPD急性加重期的临床疗效

清咳平喘颗粒对COPD急性加重期的临床疗效

扫码查看
目的 探讨清咳平喘颗粒对慢性阻塞性肺疾病急性加重期(AECOPD)患者临床疗效的影响.方法 选取80例呼吸科住院治疗的AECOPD患者,其中常规组和联合组各40例,分别于治疗前、治疗第2周末、治疗1个月后观察2组患者自我评估测试(CAT)评分、疗效指数、白细胞介素(IL)-6水平、C-反应蛋白(CRP)水平、第1秒用力呼气容积(FEV1)/用力肺活量(FVC)、FEV1占预计值百分比(FEV1%pred)的差异.结果 联合组总有效率高于常规组(92.5%vs.75.0%,P<0.05).治疗第2周末,2组FEV1%pred、FEV1/FVC、IL-6水平、CRP水平与治疗前比较均有所改善,且联合组改善程度优于常规组(P<0.05),2组患者呼吸衰竭比例均较治疗前明显好转;随访1个月,联合组CAT评分回弹率低于常规组(P<0.05);2组不良反应发生率差异无统计学意义(12.5%vs.2.5%,P>0.05).结论 清咳平喘颗粒能有效改善AECOPD患者的临床症状及肺功能,提高生活质量.
Clinical effects of Qingke Pingchuan Granule on acute exacerbation of COPD
Objective To study the effect of Qingke Pingchuan Granule on the clinical efficacy in patients with phlegm-heat obstructing lung syndrome(AECOPD).Methods A total of 80 patients with acute exacerbation of chronic obstructive pulmonary disease(syndrome of phlegm-heat stagnation in the lung)hospitalized in the respiratory department of our hospital were selected and divided into the conventional group and the combinational group,with 40 cases in each group.The CAT score,TCM syndrome score,serum IL-6,CRP,lung function FEV1%pred,and FEV1/FVC were retrospectively observed before treatment,at the end of the second week of treatment,and at the follow-up after 1 month of treatment in the two groups.Results The total effective rate was significantly better in the combinational group than that of the conventional group(92.5%vs.75.0%,P<0.05).At the end of the second week of treatment,the CAT score,each single syndrome score,serum IL-6 and CRP levels were all improved than those before treatment in the two groups(P<0.05),and the improvement degree was better in the combined group than that of the conventional group(P<0.05).The severity of airflow limitation and respiratory failure were significantly improved compared with those before treatment in both groups.At the follow-up after 1 month of treatment,the recovery rate of scores of each single syndrome score and CAT score were significantly lower in the combined group than those in the routine group(P<0.05).There were no significant differences in adverse drug reactions between the two groups(12.5%and 2.5%,P>0.05).Conclusion Qingke Pingchuan Granule can effectively relieve the symptoms and improve lung function and the quality of life of AECOPD patients.

pulmonary disease,chronic obstructiveturbid phlegm obstructing lungintegrated chinese traditional and western medicine therapyQingke Pingchuan Granule

李冬生、秦艺榕、乔曼、迟航、崔青敏、李晓秋

展开 >

天津市南开医院呼吸与危重症医学科(邮编 300100)

肺疾病,慢性阻塞性 痰浊阻肺 中西医结合疗法 清咳平喘颗粒

2024

天津医药
天津市医学科学技术信息研究所

天津医药

CSTPCD
影响因子:1.107
ISSN:0253-9896
年,卷(期):2024.52(8)